Apolipoprotein E Genotype and SchizophreniaChen J.-Y.a · Hong C.-J.b,c · Chiu H.-J.b,c · Lin C.-Y.a · Bai Y.-M.a · Song H.-L.c · Lai H.-C.c · Tsai S.-J.b,c
aSection of Psychiatry, Yu-Li Veterans Hospital, bDivision of Psychiatry, School of Medicine, National Yang-Ming University, and cDepartment of Psychiatry, Veterans General Hospital, Taipei, Taiwan, ROC Neuropsychobiology 1999;39:141–143 (DOI:10.1159/000026573)
Schizophrenic disorders are complex genetic disorders and may involve multiple genes of small effect. The presence of apolipoprotein E (apoE) is associated with several neuropsychiatric disorders. Previous studies on apoE genotype distribution in schizophrenia have reported conflicting findings. We studied the genotype frequencies in a large group of schizophrenic patients. The genotype distribution was significantly different between the schizophrenic patients and the control subjects. Persons who were σ3 carriers have an increased risk of schizophrenia. This result suggests that apoE isoforms may play a functional role in the pathogenesis of schizophrenic disorders. Some possible mechanisms regarding the effect of apoE on the development of schizophrenia are discussed.
|Direct payment||This item at the regular price: USD 33.00|
|Payment from account||With a Karger Pay-per-View account (down payment USD 150)
you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00